MGLCX
Price
$17.95
Change
+$0.02 (+0.11%)
Updated
Aug 14 closing price
Net Assets
2.18B
RRSRX
Price
$33.06
Change
+$0.04 (+0.12%)
Updated
Aug 14 closing price
Net Assets
413.9M
Interact to see
Advertisement

MGLCX vs RRSRX

MGLCX vs RRSRX Comparison Chart in %
View a ticker or compare two or three
VS
MGLCX vs. RRSRX commentary
Aug 16, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MGLCX is a Buy and RRSRX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
MGLCX has more cash in the bank: 2.18B vs. RRSRX (414M). RRSRX pays higher dividends than MGLCX: RRSRX (2.74) vs MGLCX (1.83). MGLCX was incepted earlier than RRSRX: MGLCX (12 years) vs RRSRX (10 years). MGLCX (1.94) is less costly to investors than RRSRX (1.02). RRSRX is a more actively managed with annual turnover of: 67.00 vs. MGLCX (35.00). RRSRX has a lower initial minimum investment than MGLCX: RRSRX (0) vs MGLCX (1000). RRSRX annual gain was more profitable for investors over the last year : 13.71 vs. MGLCX (12.21). RRSRX return over 5 years is better than : -1.03 vs. MGLCX (-12.32).
MGLCXRRSRXMGLCX / RRSRX
Total Expense Ratio1.930.92210%
Annual Report Gross Expense Ratio1.941.02190%
Fund Existence12 years10 years-
Gain YTD10.81610.94399%
Front LoadN/AN/A-
Min. Initial Investment10000-
Min. Initial Investment IRAN/AN/A-
Net Assets2.18B414M527%
Annual Yield % from dividends1.832.7467%
Returns for 1 year12.2113.7189%
Returns for 3 years20.2033.1861%
Returns for 5 years-12.32-1.031,197%
Returns for 10 years16.6016.26102%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SUPN48.271.12
+2.38%
Supernus Pharmaceuticals
MPLT11.750.17
+1.47%
MapLight Therapeutics Inc.
TXT89.000.96
+1.09%
Textron
CPHC15.61-0.20
-1.27%
Canterbury Park Holding Corp
RCON0.03N/A
-7.25%
Recon Technology Ltd.